This Key Event Relationship is licensed under the Creative Commons BY-SA license. This license allows reusers to distribute, remix, adapt, and build upon the material in any medium or format, so long as attribution is given to the creator. The license allows for commercial use. If you remix, adapt, or build upon the material, you must license the modified material under identical terms.
Relationship: 933
Title
Binding of inhibitor, NADH-ubiquinone oxidoreductase (complex I) leads to Inhibition, NADH-ubiquinone oxidoreductase (complex I)
Upstream event
Downstream event
AOPs Referencing Relationship
| AOP Name | Adjacency | Weight of Evidence | Quantitative Understanding | Point of Contact | Author Status | OECD Status |
|---|---|---|---|---|---|---|
| Inhibition of the mitochondrial complex I of nigro-striatal neurons leads to parkinsonian motor deficits | adjacent | High | Low | Cataia Ives (send email) | Open for citation & comment | WPHA/WNT Endorsed |
| Inhibition of complex I of the electron transport chain leading to chemical induced Fanconi syndrome | adjacent | Not Specified | Not Specified | Evgeniia Kazymova (send email) | Under development: Not open for comment. Do not cite | |
| Mitochondrial complex inhibition leading to liver injury | adjacent | Not Specified | Not Specified | Arthur Author (send email) | Under development: Not open for comment. Do not cite |
Taxonomic Applicability
Sex Applicability
Life Stage Applicability
It is well documented that binding of an inhibitor to CI inhibits its activity (see MIE). Naturally occurring and synthetic CI inhibitors have been shown to inhibit the catalytic activity of CI, leading to partial or total inhibition of its activity in a dose response manner (Degli Esposti and Ghelli, 1994; Ichimaru et al. 2008; Barrientos and Moraes, 1999; Betarbet et al., 2000). Indeed, binding of inhibitors stops the electron flow from CI to ubiquinone. Therefore, the Fe-S clusters of CI become highly reduced and no further electrons can be transferred from NADH to CI. This leads to the inhibition of the NADH oxido-reductase function, i.e. CI inhibition.
| ID | Experimental Design | Species | Upstream Observation | Downstream Observation | Citation (first author, year) | Notes |
|---|
| Title | First Author | Biological Plausibility |
Dose Concordance |
Temporal Concordance |
Incidence Concordance |
|---|
Biological Plausibility
Dose Concordance Evidence
Temporal Concordance Evidence
Incidence Concordance Evidence
Uncertainties and Inconsistencies
It is not clear the number of subunits constituting CI in mammals, as according to the existing literature different numbers are cited (between 41-46) (Vogel et al., 2007a; Hassinen, 2007). The majority of data claims that mammalian CI is composed of 46 (Greenamyre et al., 2001; Hassinen, 2007) or 45 subunits (Vogel et al., 2007a). It is not sure whether there may exist tissue-specific subunits of CI isoforms (Fearnley et al., 2001). It is unclear, which subunit(s) bind rotenone or other inhibitors of CI. Additionally, it is not clear whether CI has other uncharacterized functions, taking into consideration its size and complexity (43-46 subunits vs. 11 subunits of complex III or 13 subunits of complex IV) (Greenamyre et al., 2001). There is no strict linear relationship between inhibitor binding and reduced mitochondrial function. Low doses of rotenone that inhibit CI activity partially do not alter mitochondrial oxygen consumption. Therefore, bioenergetic defects can not account alone for rotenone-induced neurodegeneration. Instead, under such conditions, rotenone neurotoxicity may result from oxidative stress (Betarbet et al., 2000). Few studies used human brain cells/human brain mitochondria. Therefore, full quantitative data for humans are not available.
The kinetics of binding and CI inhibition by rotenone has been quantitatively evaluated in a dose-dependent manner using the sub-mitochondrial particles (Grivennikova et al., 1997). The consequences of CI inhibition were quantitatively measured by a variety of assays that are used to study mitochondrial dysfunction (see Key Event Relationship (KER): Inhibition of Complex I leads to mitochondrial dysfunction). There are also many in vitro and in vivo studies combining the quantification of CI inhibition and DA cell death (e.g. Choi et al., 2008, Betarbet et al., 2000, see KER Mitochondrial dysfunction induces degeneration of nigrostriatal pathway).
The binding of different classes of inhibitors (e.g., pesticides, drugs and other toxins) to CI has been determined quantitatively and I50, and KI values are available. Potency relative to that of rotenone has been determined under the same conditions in beef mitochondria or submitochondrial particles using the ratio of the KI values, when they were available (Degli Esposti, 1998; Okun et al., 1999). Rotenone I50 value is defined as 20 nM (Okun et al., 1999).
Example of a quantitative evaluation of concentration-dependent CI inhibition by rotenone (Fig. 1 from Barrientos and Moraes, 1999).
Fig. 1. Fig.1. Effect of CI (NADH decylubiquinone reductase) inhibition on endogenous cell respiration. Cells were treated with different concentrations of rotenone for 4 h before measuring cell respiration in whole cells and CI activity in isolated mitochondria. Complete CI inhibition was achieved with 100 nM rotenone. The cell respiration was inhibited also in a dose-dependent manner but showed different inhibition kinetics and a saturation threshold. For comparison, the genetically-altered cell line HXC had an approximately 40% CI reduced activity and an approximately 80% residual cell respiration. HXC, human xenomitochondrial cybrids.
Time- and concentration-relationship of NADH oxidase inhibition by rotenone (Fig. 2. from Grivennikova et al., 1997).
Fig. 2. Panel A and B: Time- and concentration-relationship of NADH oxidase inhibition by rotenone. The numbers on the curves indicate the final concentrations of rotenone (0, 20, 30, 40, 1000 nM). In Panel B: vo, zero-order rate of NADH oxidation in the absence of rotenone; vt, the `instant' values of the rates approximated within 10 s time intervals. Panel C: The dependence of first-order inhibition rate constant on the concentration of rotenone (for further description see Fig. 1 in Grivennikova et al., 1997).
Quantitative evaluation of the 1st KER: Binding of inhibitor to NADH-ubiquinone oxidoreductase (MIE; KE upstream) leads to its inhibition (KE downstream).
|
MIE (KE upstream) Binding of inhibitor to NADH-ubiquinone oxidoreductase (nM) |
KE (downstream) Inhibition of CI (%, approximately) |
Comments (in vivo, in vitro or human studies) |
References |
|
Administration of rotenone at 2 mg/kg per day for 2 days resulted in free rotenone concentration of 20–30 nM in the brain. |
75% |
DA neuronal cell death determined after rotenone administration at 1 to 12 mg/kg per day, Sprague Dawley and Lewis rats infused continuously by jugular vein, 7days up to 5 weeks |
Betarbet et al., 2000 |
|
20 nM rotenone Direct binding studies using bovine and Musca domestica sub-mitochondrial particles |
50% |
Binding studies that defined the I50 and Kd values for three classes of CI inhibitors (12 chemicals) including rotenone. |
Okun et al., 1999 |
|
Human skin fibroblasts exposed to 100 nM Rotenone for 72 hr |
20% |
In the same experiment mitochondria morphology, motility was also evaluated. |
Koopman et al., 2007 |
|
0-2.5 nM Rotenone 5/10 nM Rotenone Mesencephalic neurons were cultured from E14 C57/BL6 mouse embryos for 6 days and then treated with rotenone for 24 hr |
No effect 11% and33%, respectively |
Treatments with 5 or 10 nM rotenone killed 50% or 75% DA neurons respectively. |
Choi et al., 2008 |
|
1-2.5-5-7.5-10-20 nM 1-10-20-80 nM |
10-20-35-50- 65-80 % 5- 75 % |
In this study time course of the active and deactivated enzymes inhibition by rotenone and Piericidin A is study in a dose-dependent manner. Binding studies in sub-mitochondrial particles prepared from bovine heart after 20 min of exposure to rotenone. |
Grivennikova et al., 1997 |
|
5-10 nM 20 nM 40 nM 100 nM 143B Cells (human osteo-sarcoma), exposed for 4 hrs to rotenone |
55-78 % 80% 87% 100% |
In the same study similar experiments were performed using HXC cell line (see Fig. 1 above). |
Barrientos and Moraes 1999 |
Response-response Relationship
Time-scale
Known Feedforward/Feedback loops influencing this KER
The CI is well-conserved across species from lower organism to mammals. The central subunits of CI harboring the bioenergetic core functions are conserved from bacteria to humans. CI from bacteria and from mitochondria of Yarrowia lipolytica, a yeast genetic model for the study of eukaryotic CI (Kerscher et al., 2002) was analyzed by x-ray crystallography (Zickermann et al., 2015). However, the affinity of various chemicals to cause partial or total inhibition of CI activity across species is not well studied (except rotenone).

